悦心健康
(002162)
| 流通市值：39.31亿 | | | 总市值：39.36亿 |
| 流通股本：9.18亿 | | | 总股本：9.20亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 239,544,966.43 | 233,629,055.22 | 332,008,543.87 | 284,419,506.81 |
| 结算备付金 | 0 | 0 | 0 | - |
| 拆出资金 | 0 | 0 | - | - |
| 衍生金融资产 | 0 | 0 | - | - |
| 应收票据及应收账款 | 147,343,591.71 | 164,373,857.23 | 210,687,174.5 | 226,859,345.37 |
| 其中：应收票据 | 20,420,679.97 | 16,053,282.2 | 6,098,462.41 | 6,423,564.72 |
| 应收账款 | 126,922,911.74 | 148,320,575.03 | 204,588,712.09 | 220,435,780.65 |
| 应收款项融资 | 2,001,087.73 | 3,130,891.68 | 273,017.16 | 796,855.15 |
| 预付款项 | 34,710,337.68 | 26,934,479.4 | 34,375,198.33 | 28,167,045.64 |
| 应收保费 | 0 | 0 | - | - |
| 应收分保账款 | 0 | 0 | - | - |
| 应收分保合同准备金 | 0 | 0 | - | - |
| 其他应收款合计 | 18,400,795.43 | 21,540,329.51 | 25,516,319.18 | 33,403,131.95 |
| 其中:应收利息 | 0 | 0 | - | - |
| 应收股利 | 0 | 0 | - | - |
| 买入返售金融资产 | 0 | 0 | - | - |
| 存货 | 165,677,380.82 | 160,130,242.49 | 166,933,456.69 | 194,620,717.01 |
| 合同资产 | 0 | 0 | - | - |
| 一年内到期的非流动资产 | 38,905,511.8 | 38,697,142.19 | 38,488,479.27 | 38,277,778.76 |
| 其他流动资产 | 19,272,866.66 | 1,775,852.23 | 10,828,462.83 | 209,924.11 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 665,856,538.26 | 650,211,849.95 | 819,110,651.83 | 806,754,304.8 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | 0 | - | - |
| 债权投资 | 0 | 0 | - | - |
| 其他债权投资 | 0 | 0 | - | - |
| 长期应收款 | 0 | 0 | 39,332,657.52 | 39,117,335.67 |
| 长期股权投资 | 249,635,747.97 | 252,080,518.63 | 252,645,180.95 | 253,122,480.58 |
| 其他权益工具投资 | 0 | 0 | - | - |
| 其他非流动金融资产 | 70,181,865 | 70,181,865 | 66,960,926.23 | 70,085,926.23 |
| 投资性房地产 | 534,749,100 | 534,749,100 | 532,793,300 | 532,793,300 |
| 固定资产 | 285,866,661.06 | 292,378,291.16 | 312,695,867.21 | 319,978,027 |
| 在建工程 | 9,587,927.2 | 4,842,678.4 | 3,940,719.06 | 8,169,319.79 |
| 生产性生物资产 | 0 | 0 | - | - |
| 油气资产 | 0 | 0 | - | - |
| 使用权资产 | 42,088,916.87 | 41,654,310.69 | 43,697,276.11 | 51,897,150.39 |
| 无形资产 | 31,437,184.71 | 31,816,395.59 | 33,066,876.18 | 32,682,262.6 |
| 开发支出 | - | 0 | - | - |
| 商誉 | 0 | 0 | 18,615,659.4 | 18,615,659.4 |
| 长期待摊费用 | 30,641,442.67 | 32,725,906.3 | 32,292,734.04 | 26,444,289.5 |
| 递延所得税资产 | 33,913,139.33 | 33,913,139.33 | 67,458,605.29 | 68,048,448.89 |
| 其他非流动资产 | 110,427,992.09 | 113,370,472.43 | 21,548,203.48 | 22,002,759.93 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,398,529,976.9 | 1,407,712,677.53 | 1,425,048,005.47 | 1,442,956,959.98 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,064,386,515.16 | 2,057,924,527.48 | 2,244,158,657.3 | 2,249,711,264.78 |
| 流动负债: | | | | |
| 短期借款 | 279,839,096.97 | 214,646,240.71 | 284,321,248.99 | 250,643,989.16 |
| 向中央银行借款 | 0 | 0 | - | - |
| 吸收存款及同业存放 | 0 | 0 | - | - |
| 拆入资金 | 0 | 0 | - | - |
| 交易性金融负债 | 0 | 0 | - | - |
| 衍生金融负债 | 0 | 0 | - | - |
| 应付票据及应付账款 | 284,907,513.85 | 319,133,224.24 | 270,488,395.5 | 335,618,463.17 |
| 其中：应付票据 | 126,550,548.6 | 124,217,034.2 | 80,450,000 | 131,639,000 |
| 应付账款 | 158,356,965.25 | 194,916,190.04 | 190,038,395.5 | 203,979,463.17 |
| 预收款项 | 0 | 0 | - | - |
| 合同负债 | 51,335,364.87 | 64,685,457.04 | 56,556,959.65 | 42,940,301.14 |
| 卖出回购金融资产款 | 0 | 0 | - | - |
| 应付手续费及佣金 | 0 | 0 | - | - |
| 应付职工薪酬 | 17,116,255.12 | 29,585,153.72 | 24,314,011.74 | 12,511,193.56 |
| 应交税费 | 8,596,889.03 | 7,000,231.96 | 10,409,409.76 | 7,367,790.44 |
| 其他应付款合计 | 88,667,384.85 | 80,278,483.57 | 83,485,333.04 | 85,273,522.55 |
| 其中:应付利息 | 0 | 0 | - | - |
| 应付股利 | 0 | 0 | - | - |
| 应付分保账款 | 0 | 0 | - | - |
| 保险合同准备金 | 0 | 0 | - | - |
| 代理买卖证券款 | 0 | 0 | - | - |
| 代理承销证券款 | 0 | 0 | - | - |
| 一年内到期的非流动负债 | 35,298,548.4 | 33,323,975.9 | 35,737,305.55 | 35,078,597.39 |
| 其他流动负债 | 14,609,069.92 | 10,350,204.01 | 56,002,666.72 | 6,245,662.05 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 780,370,123.01 | 759,002,971.15 | 821,315,330.95 | 775,679,519.46 |
| 非流动负债: | | | | |
| 长期借款 | 285,000,000 | 288,750,000 | 298,500,000 | 305,250,000 |
| 应付债券 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 租赁负债 | 25,250,991.77 | 27,899,594.56 | 31,803,758.9 | 37,448,866.02 |
| 长期应付款 | 0 | 0 | - | - |
| 长期应付职工薪酬 | 0 | 0 | - | - |
| 预计负债 | 0 | 0 | - | - |
| 递延收益 | 2,572,082.93 | 2,572,082.93 | 3,165,640.61 | 3,165,640.61 |
| 递延所得税负债 | 134,044,387.98 | 134,044,387.98 | 134,507,744.49 | 136,428,390.6 |
| 其他非流动负债 | 1,877,277.96 | 1,877,277.96 | 2,999,918.43 | 2,999,918.43 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 448,744,740.64 | 455,143,343.43 | 470,977,062.43 | 485,292,815.66 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,229,114,863.65 | 1,214,146,314.58 | 1,292,292,393.38 | 1,260,972,335.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 921,985,453 | 921,584,303 | 920,301,277 | 920,301,277 |
| 其他权益工具 | 0 | 0 | - | - |
| 优先股 | 0 | 0 | - | - |
| 永续债 | 0 | 0 | - | - |
| 资本公积 | 186,507,282.15 | 185,540,510.65 | 181,564,140.46 | 181,564,140.46 |
| 减:库存股 | 0 | 0 | - | 0 |
| 其他综合收益 | 67,091,716.57 | 67,091,716.57 | 67,074,126.6 | 67,033,418.76 |
| 专项储备 | 0 | 0 | - | - |
| 盈余公积 | 72,853,943.26 | 72,853,943.26 | 72,853,943.26 | 72,853,943.26 |
| 一般风险准备 | 0 | 0 | - | - |
| 未分配利润 | -428,902,456.13 | -420,574,250.02 | -306,522,509.63 | -271,020,761.6 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 819,535,938.85 | 826,496,223.46 | 935,270,977.69 | 970,732,017.88 |
| 少数股东权益 | 15,735,712.66 | 17,281,989.44 | 16,595,286.23 | 18,006,911.78 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 835,271,651.51 | 843,778,212.9 | 951,866,263.92 | 988,738,929.66 |
| 负债和股东权益合计 | 2,064,386,515.16 | 2,057,924,527.48 | 2,244,158,657.3 | 2,249,711,264.78 |
| 公告日期 | 2025-04-26 | 2025-02-28 | 2024-10-26 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |